首页> Cancer prevention research (Philadelphia, Pa.)> Isorhapontigenin (ISO) Inhibits Invasive Bladder Cancer Formation In Vivo and Human Bladder Cancer Invasion In Vitro by Targeting STAT1/FOXO1 Axis.

Isorhapontigenin (ISO) Inhibits Invasive Bladder Cancer Formation In Vivo and Human Bladder Cancer Invasion In Vitro by Targeting STAT1/FOXO1 Axis.

导出 OA

翻译打印收藏纠错

第一作者： Guosong,Jiang

第一单位： Nelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, New York.

作者： Guosong,Jiang ^[1] ; Amy D,Wu ^[1] ; Chao,Huang ^[1] ; Jiayan,Gu ^[2] ; Liping,Zhang ^[2] ; Haishan,Huang ^[2] ; Xin,Liao ^[1] ; Jingxia,Li ^[1] ; Dongyun,Zhang ^[1] ; Xingruo,Zeng ^[1] ; Honglei,Jin ^[1] ; Haojie,Huang ^[3] ; Chuanshu,Huang ^[4]

作者单位： Nelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, New York. ^[1] Zhejiang Provincial Key Laboratory for Technology and Application of Model Organisms, School of Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China. ^[2] Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, Minnesota. ^[3] Nelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, New York. chuanshu@env.med.nyu.edu. ^[4]